no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A heterologous prime–boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis
|
Gonzalo, Rosa M |
|
2002 |
20 |
7-8 |
p. 1226-1231 6 p. |
article |
2 |
A new accelerated vaccination schedule for rapid protection against hepatitis A and B
|
Nothdurft, H.D |
|
2002 |
20 |
7-8 |
p. 1157-1162 6 p. |
article |
3 |
Announcement: Microarrays Immune Response
|
|
|
2002 |
20 |
7-8 |
p. XXXVI- 1 p. |
article |
4 |
Announcement: Therapeutic Vaccine agains
|
|
|
2002 |
20 |
7-8 |
p. XXXVII- 1 p. |
article |
5 |
A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants
|
Dus Santos, Marı́a J |
|
2002 |
20 |
7-8 |
p. 1141-1147 7 p. |
article |
6 |
A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector
|
Shiau, Ai-Li |
|
2002 |
20 |
7-8 |
p. 1186-1195 10 p. |
article |
7 |
Author Index (to Vol. 19,2001)
|
|
|
2002 |
20 |
7-8 |
p. I-XVI nvt p. |
article |
8 |
Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections
|
Monath, Thomas P |
|
2002 |
20 |
7-8 |
p. 1004-1018 15 p. |
article |
9 |
Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines
|
Ragupathi, Govindaswami |
|
2002 |
20 |
7-8 |
p. 1030-1038 9 p. |
article |
10 |
Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 library
|
Mukai, Tetsu |
|
2002 |
20 |
7-8 |
p. 1181-1185 5 p. |
article |
11 |
Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint
|
Ho, Jason |
|
2002 |
20 |
7-8 |
p. 1169-1180 12 p. |
article |
12 |
Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses
|
Kemp, J.M |
|
2002 |
20 |
7-8 |
p. 1089-1098 10 p. |
article |
13 |
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine
|
Konishi, Eiji |
|
2002 |
20 |
7-8 |
p. 1058-1067 10 p. |
article |
14 |
DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater
|
Nyika, Aceme |
|
2002 |
20 |
7-8 |
p. 1215-1225 11 p. |
article |
15 |
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes
|
Gilbert, Sarah C |
|
2002 |
20 |
7-8 |
p. 1039-1045 7 p. |
article |
16 |
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
|
Treanor, John |
|
2002 |
20 |
7-8 |
p. 1099-1105 7 p. |
article |
17 |
Evaluation of immunization practices in Naples–Italy
|
Simonetti, Andrea |
|
2002 |
20 |
7-8 |
p. 1046-1049 4 p. |
article |
18 |
Familial adverse events after measles–mumps–rubella (MMR) vaccination
|
Guala, Andrea |
|
2002 |
20 |
7-8 |
p. 991- 1 p. |
article |
19 |
Frequency and causes of vaccine wastage
|
Setia, Sabeena |
|
2002 |
20 |
7-8 |
p. 1148-1156 9 p. |
article |
20 |
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing
|
Pugachev, Konstantin V |
|
2002 |
20 |
7-8 |
p. 996-999 4 p. |
article |
21 |
Human therapeutic cocaine vaccine: safety and immunogenicity
|
Kosten, Thomas R |
|
2002 |
20 |
7-8 |
p. 1196-1204 9 p. |
article |
22 |
Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillance
|
Pebody, R.G |
|
2002 |
20 |
7-8 |
p. 1134-1140 7 p. |
article |
23 |
Impact of a regional Hib vaccination programme in Italy
|
Gallo, Giovanni |
|
2002 |
20 |
7-8 |
p. 993-995 3 p. |
article |
24 |
Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis
|
Buddle, Bryce M |
|
2002 |
20 |
7-8 |
p. 1126-1133 8 p. |
article |
25 |
Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies
|
Patil, P.K |
|
2002 |
20 |
7-8 |
p. 1163-1168 6 p. |
article |
26 |
Keyword Index to: Volume 19
|
|
|
2002 |
20 |
7-8 |
p. XVII-XXXV nvt p. |
article |
27 |
Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines
|
Kim, Y |
|
2002 |
20 |
7-8 |
p. 1248-1258 11 p. |
article |
28 |
Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine
|
Greenbaum, Evgenia |
|
2002 |
20 |
7-8 |
p. 1232-1239 8 p. |
article |
29 |
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
|
Lu, Xiuhua |
|
2002 |
20 |
7-8 |
p. 1019-1029 11 p. |
article |
30 |
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad–Zagreb mumps strain
|
da Cunha, Sérgio Souza |
|
2002 |
20 |
7-8 |
p. 1106-1112 7 p. |
article |
31 |
Oxidised mannan as a novel adjuvant inducing mucosal IgA production
|
Stambas, John |
|
2002 |
20 |
7-8 |
p. 1068-1078 11 p. |
article |
32 |
Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination
|
Hasegawa, Hideki |
|
2002 |
20 |
7-8 |
p. 1050-1057 8 p. |
article |
33 |
Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets
|
Hong, Wenzhou |
|
2002 |
20 |
7-8 |
p. 1205-1214 10 p. |
article |
34 |
Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
|
Halperin, Scott A |
|
2002 |
20 |
7-8 |
p. 1240-1247 8 p. |
article |
35 |
The cost-effectiveness of varicella vaccination in Canada
|
Brisson, M |
|
2002 |
20 |
7-8 |
p. 1113-1125 13 p. |
article |
36 |
The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant
|
Scanlen, M |
|
2002 |
20 |
7-8 |
p. 1079-1088 10 p. |
article |
37 |
Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine
|
Studdert, Michael J |
|
2002 |
20 |
7-8 |
p. 992- 1 p. |
article |
38 |
Vaccine quality—can a single standard be defined?
|
Milstien, Julie |
|
2002 |
20 |
7-8 |
p. 1000-1003 4 p. |
article |